Proof of Concept Study for Designed Multiple Ligands Targeting the Dopamine D2, Serotonin 5-HT2A, and Muscarinic M1 Acetylcholine Receptors

被引：11

作者：

Szabo, Monika ^{[1
]}

Lim, Herman D. ^{[1
]}

Herenbrink, Carmen Klein ^{[1
]}

Christopoulos, Arthur ^{[1
]}

Lane, J. Robert ^{[1
]}

Capuano, Ben ^{[1
]}

机构：

[1] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2015年 / 58卷 / 03期

基金：

英国医学研究理事会;

关键词：

ALLOSTERIC MODULATORS; AGONIST; DRUGS; ANTIPSYCHOTICS; DISCOVERY; MODES; LEAD;

D O I：

10.1021/jm5013243

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Herein we describe the hybridization of a benzoxazinone M-1 scaffold with D-2 privileged structures derived from putative and clinically relevant antipsychotics to develop designed multiple ligands. The M-1 mAChR is an attractive target for the cognitive deficits in key CNS disorders. Moreover, activity at D-2 and 5-HT2A receptors has proven useful for antipsychotic efficacy. We identified 9 which retained functional activity at the target M-1 mAChR and D2R and demonstrated high affinity for the 5-HT2AR.

引用

页码：1550 / 1555

页数：6

共 50 条

[21] Blockade of MK-801-Induced Heat Shock Protein 72/73 in Rat Brain by Antipsychotic and Monoaminergic Agents Targeting D2, 5-HT1A, 5-HT2A and α1-Adrenergic Receptors
Romon, Tamara
Planas, Anna M.
Adell, Albert
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (01) : 104 - 111
[22] The receptor mechanisms underlying the disruptive effects of haloperidol and clozapine on rat maternal behavior: A double dissociation between dopamine D2 and 5-HT2A/2C receptors
Zhao, Changjiu
Li, Ming
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2009, 93 (04) : 433 - 442
[23] The clozapirte metabolite N-desmethylclozapine displays variable activity in diverse functional assays at human dopamine D2 and serotonin 5-HT1A receptors
Heusler, Peter
Slot, Liesbeth Bruins
Tourette, Amelie
Tardif, Stephanie
Cussac, Didier
EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 669 (1-3) : 51 - 58
[24] Indoloquinolizidine-Peptide Hybrids as Multiple Agonists for D1 and D2 Dopamine Receptors
Vendrell, Marc
Soriano, Aroa
Casado, Vicent
Luis Diaz, Jose
Lavilla, Rodolfo
Canela, Enric I.
Lluis, Carme
Franco, Rafael
Albericio, Fernando
Royo, Miriam
CHEMMEDCHEM, 2009, 4 (09) : 1514 - 1522
[25] Screening of 64 Tryptamines at NMDA, 5-HT1A, and 5-HT2A Receptors: A Comparative Binding and Modeling Study
Berger, M. L.
Palangsuntikul, R.
Rebernik, P.
Wolschann, P.
Berner, H.
CURRENT MEDICINAL CHEMISTRY, 2012, 19 (18) : 3044 - 3057
[26] Putative antipsychotics with pronounced agonism at serotonin 5-HT1A and partial agonist activity at dopamine D2 receptors disrupt basal PPI of the startle reflex in rats
Auclair, Agnes L.
Galinier, Alexandra
Besnard, Joel
Newman-Tancredi, Adrian
Depoortere, Ronan
PSYCHOPHARMACOLOGY, 2007, 193 (01) : 45 - 54
[27] Model structure–activity relationship studies of potential tropane 5HT1A, 5HT2A, and D2 receptor ligands
Tomasz Słowiński
Jacek Stefanowicz
Martyna Z. Wróbel
Franciszek Herold
Andrzej Mazurek
Franciszek Pluciński
Aleksander P. Mazurek
Irena Wolska
Medicinal Chemistry Research, 2013, 22 : 3148 - 3153
[28] Comparison of the anti-dopamine D2 and anti-serotonin 5-HT2A activities of chlorpromazine, bromperidol, haloperidol and second-generation antipsychotics parent compounds and metabolites thereof
Suzuki, Hidenobu
Gen, Keishi
Inoue, Yuichi
JOURNAL OF PSYCHOPHARMACOLOGY, 2013, 27 (04) : 396 - 400
[29] Crystal structures of dual dopamine D2 and serotonin 5-HT1A active arylpiperidinyl-2(1H)-3,4-dihydroquinolinones
Ullah, N.
Altaf, M.
Mansha, M.
Ba-Salem, A. O.
JOURNAL OF STRUCTURAL CHEMISTRY, 2015, 56 (07) : 1441 - 1445
[30] Model structure-activity relationship studies of potential tropane 5HT1A, 5HT2A, and D2 receptor ligands
Slowinski, Tomasz
Stefanowicz, Jacek
Wrobel, Martyna Z.
Herold, Franciszek
Mazurek, Andrzej
Plucinski, Franciszek
Mazurek, Aleksander P.
Wolska, Irena
MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (07) : 3148 - 3153

← 1 2 3 4 5 →